Log in

OTCMKTS:RGINRegenicin Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Today's Range
Now: $0.01
50-Day Range
MA: $0.01
52-Week Range
Now: $0.01
Volume10,400 shs
Average Volume55,989 shs
Market Capitalization$1.81 million
P/E RatioN/A
Dividend YieldN/A
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. Its development products include NovaDerm, a cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was founded in 2007 and is based in Little Falls, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:RGIN



Sales & Book Value

Annual SalesN/A
Book Value($0.02) per share


Net Income$-760,000.00


Market Cap$1.81 million
Next Earnings DateN/A
OptionableNot Optionable

Receive RGIN News and Ratings via Email

Sign-up to receive the latest news and ratings for RGIN and its competitors with MarketBeat's FREE daily newsletter.

Regenicin (OTCMKTS:RGIN) Frequently Asked Questions

How has Regenicin's stock been impacted by COVID-19 (Coronavirus)?

Regenicin's stock was trading at $0.0185 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, RGIN stock has decreased by 36.2% and is now trading at $0.0118. View which stocks have been most impacted by Coronavirus.

Has Regenicin been receiving favorable news coverage?

Media stories about RGIN stock have been trending negative this week, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Regenicin earned a media sentiment score of -2.4 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news about Regenicin.

Who are some of Regenicin's key competitors?

What other stocks do shareholders of Regenicin own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Regenicin investors own include Amarantus Bioscience (AMBS), Energous (WATT), Vital Therapies (VTL), Xerox (XRX), Allergan (AGN), Leafbuyer Technologies (LBUY), Cheniere Energy (LNG), Horsehead (ZINCQ), Ambarella (AMBA) and Alstom (ALO).

Who are Regenicin's key executives?

Regenicin's management team includes the following people:
  • Mr. Randall McCoy, Chairman, CEO & Pres (Age 70)
  • Mr. John J. Weber, CFO & Director (Age 69)
  • Dr. J. Roy Nelson, Chief Science Officer (Age 71)

What is Regenicin's stock symbol?

Regenicin trades on the OTCMKTS under the ticker symbol "RGIN."

How do I buy shares of Regenicin?

Shares of RGIN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Regenicin's stock price today?

One share of RGIN stock can currently be purchased for approximately $0.01.

How big of a company is Regenicin?

Regenicin has a market capitalization of $1.81 million. Regenicin employs 3 workers across the globe.

What is Regenicin's official website?

The official website for Regenicin is www.regenicin.com.

How can I contact Regenicin?

Regenicin's mailing address is 10 HIGH COURT, LITTLE FALLS NJ, 07424. The company can be reached via phone at 973-557-8914.

This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.